AMPK attenuates bupivacaine-induced neurotoxicity

Journal of Dental Research

Volumn 89, Issue 8, 2010, Pages 797-801

  Lee, S J ^a   Shin, T J ^a   Kang, I S ^b   Ha, J H ^a   Lee, S C ^a   Kim, H J ^a  

^a Seoul National University   (South Korea)

^b Kyung Hee University Hospital   (South Korea)

Author keywords

AMP activated protein kinases; bupivacaine; Schwann cell

Indexed keywords

ACETYLCARNITINE; BUPIVACAINE; ENZYME ACTIVATOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LOCAL ANESTHETIC AGENT; NEUROPROTECTIVE AGENT;

ANALYSIS OF VARIANCE; APOPTOSIS; ARTICLE; BIOSYNTHESIS; CELL LINE; CELL SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; PHYSIOLOGY; SCHWANN CELL; STATISTICAL MODEL; UPREGULATION;

ACETYLCARNITINE; AMP-ACTIVATED PROTEIN KINASES; ANALYSIS OF VARIANCE; ANESTHETICS, LOCAL; APOPTOSIS; BUPIVACAINE; CELL LINE; CELL SURVIVAL; ENZYME ACTIVATORS; HUMANS; LOGISTIC MODELS; NEUROPROTECTIVE AGENTS; SCHWANN CELLS; UP-REGULATION;

EID: 77955491465     PISSN: 00220345     EISSN: 15440591     Source Type: Journal    
DOI: 10.1177/0022034510366823     Document Type: Article

References (19)

1. Blazquez C., Geelen MJ, Velasco G., Guzman M. (2001). The AMP-activated protein kinase prevents ceramide synthesis de novo and apoptosis in astrocytes. FEBS Lett 489: 149-153.
2. Chabbouh T., Lentschener C., Zuber M., Jude N., Delaitre B., Ozier Y. (2005). Persistent cauda equina syndrome with no identifiable facilitating condition after an uneventful single spinal administration of 0.5% hyperbaric bupivacaine. Anesth Analg 101: 1847-1848.
3. Davies SP, Helps NR, Cohen PT, Hardie DG (1995). 5ĝ€2-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2Calpha and native bovine protein phosphatase-2AC. FEBS Lett 377: 421-425.
4. Diaz JH, Gould HJ 3rd (2004). Permanent neurologic symptoms after prolonged epidural analgesia. Pain Pract 4: 132-135.
5. Fortun J., Dunn WA Jr, Joy S., Li J., Notterpek L. (2003). Emerging role for autophagy in the removal of aggresomes in Schwann cells. J Neurosci 23: 10672-10680.
6. Hwang JT, Kwon DY, Park OJ, Kim MS (2008). Resveratrol protects ROSinduced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr 2: 323-326.
7. Imada M., Sueoka N. (1978). Clonal sublines of rat neurotumor RT4 and cell differentiation. I. Isolation and characterization of cell lines and cell type conversion. Dev Biol 66: 97-108.
8. Jung JE, Lee J., Ha J., Kim SS, Cho YH, Baik HH, et al. (2004). 5-Aminoimidazole-4-carboxamide-ribonucleoside enhances oxidative stress-induced apoptosis through activation of nuclear factor-kappaB in mouse neuro 2a neuroblastoma cells. Neurosci Lett 354: 197-200.
9. Kefas BA, Heimberg H., Vaulont S., Meisse D., Hue L., Pipeleers D., et al. (2003 a). AICA-riboside induces apoptosis of pancreatic beta cells through stimulation of AMP-activated protein kinase. Diabetologia 46: 250-254.
10. Kefas BA, Cai Y., Ling Z., Heimberg H., Hue L., Pipeleers D., et al. (2003 b). AMP-activated protein kinase can induce apoptosis of insulin-producing MIN6 cells through stimulation of c-Jun-N-terminal kinase. J Mol Endocrinol 30: 151-161.
11. Kewalramani G., Puthanveetil P., Wang F., Kim MS, Deppe S., Abrahani A., et al. (2009). AMP-activated protein kinase confers protection against TNF-{alpha}-induced cardiac cell death. Cardiovasc Res 84: 42-53.
12. Kim JE, Ahn MW, Baek SH, Lee IK, Kim YW, Kim JY, et al. (2008). AMPK activator, AICAR, inhibits palmitate-induced apoptosis in osteoblasts. Bone 43: 394-404.
13. Kohase H., Miyamoto T., Umino M. (2002). A new method of continuous maxillary nerve block with an indwelling catheter. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94: 162-166.
14. Leverve XM, Guigas B., Detaille D., Batandier C., Koceir EA, Chauvin C., et al. (2003). Mitochondrial metabolism and type-2 diabetes: a specific target of metformin. Diab Metabol 29 (4 Pt 2). 6S88-6S94.
15. Mayer A., Denanglaire S., Viollet B., Leo O., Andris F. (2008). AMP-activated protein kinase regulates lymphocyte responses to metabolic stress but is largely dispensable for immune cell development and function. Eur J Immunol 38: 948-956.
16. Myers R., Kalichman M., Reisner L. (1986). Neurotoxicity of local anesthetics: altered perineural permeability, edema, and nerve fiber injury. Anesthesiology 64: 29-35.
17. Park CJ, Park SA, Yoon TG, Lee SJ, Yum KW, Kim HJ (2005). Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res 84: 852-857.
18. Radwan I., Saito S., Goto F. (2002). The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg 94: 319-324.
19. Russell R. 3rd (2003). The role of AMP-activated protein kinase in fuel selection by the stressed heart. Curr Hypertens Rep 5: 459-465.